H.-J. Lehmler et al. / Journal of Fluorine Chemistry 128 (2007) 595–607
605
corresponding bromo- or iodo-alkyl derivative (5.5 mmol) were
dissolved in acetone (25 mL) and the resultant mixture was
heated under reflux until complete conversion. The reaction
mixture was allowed to cool to room temperature and filtered.
The precipitate was washed with acetone (2 ꢄ 10 mL) and the
solvent was removed by rotary evaporation under reduced
pressure. The crude product was purified by column
chromatography using silica gel with hexane and ethyl acetate
(96:4) as eluent.
(300 MHz, CDCl3): d 1.3 (3H, t, J = 7.1 Hz, –CH3), 2.1 (3H, s,
–OCOCH3), 3.4–3.9 (4H, m, –NCH2–), 4.3 (2H, t, J = 5.6 Hz, –
CH2OCOCH3); 13C NMR (75 MHz, CDCl3): d 13.8 (–CH3),
20.6 (–OCOCH3), 44.4 (–CH2CH3), 46.4 (–NCH2–), 61.2 (–
CH2OCOCH3), 170.6 (–OCOCH3); 19F NMR (288.8 MHz, d6-
acetone): d ꢀ80.5 (CF3), ꢀ112.0 (a-CF2), ꢀ119.8 (b-CF2),
ꢀ121.1 (3 ꢄ –CF2–), ꢀ122.1 (z-CF2), ꢀ125.6 (u-CF2); GC–
MS 40 eV, m/z (rel. int.): 553 [M ꢀ CH3COOH]+ (5), 540
[M ꢀ C3H5O2]+ (42), 448 [C8F16SO]+ (27). Anal. Calcd for
C14H12F17NO4S: C, 27.42; H, 1.97; S, 5.23; N, 2.28. Found: C,
27.37; H, 1.79; S, 5.26; N, 2.35.
4.4.1. N-(2-Hydroxyethyl)-N-methyl-perfluorooctane-1-
sulfonamide (9a)
Ninety-six percent; mp 83 8C; IR (KBr); n 3420 (–OH), 1384,
4.4.5. Methyl 2-(N-ethyl-perfluorooctanesulfonamido)
acetate (11)
1
1219, and 1151 cmꢀ1; H NMR (300 MHz, d6-acetone): d 3.2
(3H, s, –CH3), 3.4 (1H, m, –NCH2–), 3.7 (3H, m, –CH2CH2OH),
4.1 (1H, t, J = 5.5 Hz, –CH2OH); 13C NMR (75 MHz, CD3OD):
d 37.2 (–CH3), 54.3 (–NCH2–), 60.6 (–CH2OH); 19F NMR
(288.8 MHz, CD3OD): d –80.5 (CF3), ꢀ112.6 (a-CF2), ꢀ119.8
(b-CF2), ꢀ121.2 (3 ꢄ CF2), ꢀ122.1 (z-CF2), ꢀ125.6 (u-CF2);
MS, m/z (rel. int.): 616(50), 141(100), 119(55), 223(15). Anal.
Calcd for C11H8F17NO3S: C, 23.71; H, 1.45; S, 5.75; N, 2.51.
Found: C, 23.82; H, 1.33; S, 5.82; N, 2.53.
Ninety percent; mp 55–56 8C; IR (KBr); n 1756, 1379, 1202,
1
1180, 1167, and 1124 cmꢀ1; H NMR (300 MHz, CD3OD): d
1.24 (3H, t, J = 7.1 Hz, –CH3), 3.5–3.7 (2H, m, –CH2CH3),
3.78 (2H, s, –CH2CO2–), 4.27 (2H, s, –CO2CH3); 13C NMR
(75 MHz, CD3OD): d 13.9 (–CH3), 46.9 (–CH2CH3), 49.2 (–
CH2CO2–), 53.1 (–CO2CH3), 170.1 (–CO2CH3); 19F NMR
(288.8 MHz, CD3OD): d ꢀ80.48 (CF3), ꢀ112.41 (a-CF2),
ꢀ119.69 (b-CF2), ꢀ121.15 (3 ꢄ CF2), ꢀ122.13 (z-CF2),
ꢀ125.59 (u-CF2); GC–MS 40 eV, m/z (rel. int.): 600 [M + H]
(68), 540(50), 448(40), 56(100); Anal. Calcd for
C13H10F17NO4S: C, 26.06; H, 1.68; S, 5.35; N, 2.34. Found:
C, 26.22; H, 1.73; S, 5.32; N, 2.41.
4.4.2. N-Ethyl-N-(2-hydroxyethyl)-perfluorooctane-1-
sulfonamide (9b)
Ninety-nine percent; mp 70 8C (Lit. 65–71 8C [4]); IR
1
(KBr); n 3412 (–OH), 1384, 1212, and 1150 cmꢀ1; H NMR
(300 MHz, CDCl3): d 1.3 (3H, t, J = 7.1 Hz, –CH2CH3), 2.2
(1H, br s, –CH2OH), 3.3–3.8 (4H, m, –CH2–), 3.8 (2H, ‘‘t’’,
J = 5.3 Hz, –CH2OH); 13C NMR (75 MHz, CDCl3): d 13.9 (–
CH2CH3), 45.0 (–NCH2CH3), 49.9 (–NCH2CH2OH), 60.8 (–
CH2OH); 19F NMR (288.8 MHz, CDCl3): d ꢀ81.3 (CF3),
ꢀ112.6 (a-CF2), ꢀ120.7 (b-CF2), ꢀ122.2 (3 ꢄ –CF2–),
ꢀ123.2 (z-CF2), ꢀ126.6 (u-CF2); MS, m/z (rel. int.):
630(60), 141(100), 119(75), 223(15). Anal. Calcd for
C12H10F17NO3S: C, 25.23; H, 1.76; S, 5.61; N, 2.45. Found:
C, 25.27; H, 1.83; S, 5.71; N, 2.59.
4.5. Synthesis of 2-(N-ethyl-
perfluorooctanesulfonamido)acetic acid 12
Methyl 2-(N-ethyl-perfluorooctanesulfonamido) acetate 11
was dissolved in 1N NaOH (1.5 equiv., 1.4 mL) and 1,4-
dioxane (3 mL), stirred for 2 h at 65 8C, diluted with water
(20 mL) and filtered. The filtrate was acidified with 1N HCl
(10 mL) and extracted with ethyl acetate (ꢅ20 mL). The
organic layer was washed with water (2 ꢄ 20 mL) and dried
over sodium sulfate. The solution was treated with charcoal,
filtered and concentrated under reduced pressure to give 12 as a
white solid in 40% yield.
4.4.3. 2-(N-Methyl-perfluorooctylsulfonamido) ethyl
acetate (10a)
mp 156–157 8C (Lit. 162 8C [31]); IR (KBr); n 1728, 1379,
Eighty-six percent; mp 82–83 8C; IR (KBr); n 1732 (–C O),
1201, 1168, 1149, and 1124 cmꢀ1 1H NMR (400 MHz,
;
1
1380, 1373, 1236, 1204, and 1151 cmꢀ1; H NMR (300 MHz,
d6-acetone): d 2.9 (3H, s, –OCOCH3), 3.2 (3H, s, –NCH3), 3.5–
CD3OD): d 1.25 (3H, t, J = 7.1 Hz, –CH3), 3.63 (2H, q,
J = 7.1 Hz, –CH2CH3), 4.24–4.56 (2H, m, –CH2CO2–); 13C
NMR (75 MHz, CD3OD): d 13.9 (–CH3), 46.8 (–CH2CH3),
49.1 (–CH2CO2–), 170.1 (–CO2H); 19F NMR (288.8 MHz,
CD3OD): d ꢀ80.64 (CF3), ꢀ112.38 (a-CF2), ꢀ119.0 (b-CF2),
ꢀ121.13 (3 ꢄ CF2), ꢀ122.04 (z-CF2), ꢀ125.59 (u-CF2); MS,
m/z (rel. int.): 584(95), 141(35), 369(20), 499(20), 223(10),
217(10). Anal. Calcd for C12H8F17NO4S: C, 24.63; H, 1.38; S,
5.48; N, 2.39. Found: C, 24.37; H, 1.59; S, 5.71; N, 2.29.
4.1 (2H, m, (–NCH2–), 4.2–4.5 (2H, br m, –CH2OCOCH3); 13
C
NMR (75 MHz, d6-acetone): d 21.7 (–OCOCH3), 37.6 (–CH3),
51.8 (–NCH2–), 62.2 (–CH2OCOCH3), 171.9 (–OCOCH3); 19
F
NMR (288.8 MHz, d6-acetone): d ꢀ80.5 (CF3), ꢀ111.7 (a-CF2),
ꢀ119.9 (b-CF2), ꢀ121.2 (3 ꢄ –CF2–), ꢀ122.2 (z-CF2), ꢀ125.6
(u-CF2); GC–MS 40 eV, m/z (rel. int.): 539 [M ꢀ CH3COOH]+
(12), 526 [M ꢀ C3H6O2]+ (28), 462 [C8F16SON]+ (40). Anal.
Calcd for C13H10F17NO4S: C, 26.06; H, 1.68; S, 5.35; N, 2.34.
Found: C, 26.11; H, 1.59; S, 5.57; N, 2.46.
4.6. Synthesis of N,N-dialkyl perfluorooctanesulfonamides
using the Mitsunobu reaction
4.4.4. 2-(N-Ethyl-perfluorooctylsulfonamido) ethyl acetate
(10b)
4.6.1. General procedure for the Mitsunobu reaction [18]
A solution of DIAD (diisopropyl azodicarboxylate, 0.3 g,
15 mmol) in ether (2 mL) was added slowly to a sonicated
Ninety-two percent; mp 104 8C; IR (KBr); n 2966, 2934,
1
1732 (C O), 1379, 1240, 1214, and 1151 cmꢀ1; H NMR